9.000
+2,27%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -97.0% | -34.1% | 1 / 3 | -34.5% | +1.00 pp | -3.03 pp | +3.9% | 0.01 | 16.23 | 5,0 | −34,5% | 0,0 | −97,0% | 16.23 | 9.81 | +65,5% |
| Pts | 0 | 0 | 4 | 0 | 8 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 9.000 (close price on 2026-10-19)EPS (TTM): 554,4
Financial charts
1.Revenue & growth
VND bn5,05Q2/26
1.Revenue & growth
VND bn5,05Q2/26
2.Profit & growth
VND bn0,01Q2/26
3.Profit mix (Penman)
VND bn4,03Q2/26
4.Margins & cost structure
%11.5%Q2/26
5.Returns & cash cycle
% · days2.1%Q2/26
6.Earnings quality & cash
VND bn-0,51Q2/26
7.Asset structure
VND bn89,9Q2/26
8.Funding & debt health
VND bn · times89,9Q2/26
9.Revenue backlog
VND bn0,14Q2/26
10.Valuation
times · %16,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1Q2/26
Adjusted EPS growth, latest quarter
-97.0%
Average adjusted EPS growth, 3 quarters
-34.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26